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G6Pase location in the endoplasmic 
reticulum: Implications on 
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uptake in cancer cells
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Michele Piana1,7, Gianmario Sambuceti2,3, Giacomo Caviglia  1 & Cecilia Marini3,8
The favourable kinetics of 18F-fluoro-2-deoxyglucose (FDG) permits to depict cancer glucose 
consumption by a single evaluation of late tracer uptake. This standard procedure relies on the slow 
radioactivity loss, usually attributed to the limited tumour expression of G6P-phosphatase (G6Pase). 
However, this classical interpretation intrinsically represents an approximation since, as in all tissues, 
cancer G6Pase activity is remarkable and is confined to the endoplasmic reticulum (ER), whose lumen 
must be reached by phosphorylated FDG to explain its hydrolysis and radioactivity release. The 
present study tested the impact of G6Pase sequestration on the mathematical description of FDG 
trafficking and handling in cultured cancer cells. Our data show that accounting for tracer access to the 
ER configures this compartment as the preferential site of FDG accumulation. This is confirmed by the 
reticular localization of fluorescent FDG analogues. Remarkably enough, reticular accumulation rate of 
FDG is dependent upon extracellular glucose availability, thus configuring the same ER as a significant 
determinant of cancer glucose metabolism.
The wide clinical success of PET/CT imaging in cancer largely relies on the accumulation kinetics of 
18F-fluorodeoxyglucose (FDG) that permits to evaluate the whole body without the need for complex mathemat-
ical analysis of tracer blood-tissue exchanges. This clinical standard relies on two key observations: 1) FDG com-
petes with glucose for transmembrane transport and phosphorylation; 2) radioactivity trapped in cells cannot 
be lost. These two fundamental properties have been formalized by Sokoloff et al.1 in a seminal paper that so far 
represents the theoretical basis for the experimental use of 14C-2DG and for the clinical value of FDG uptake2. The 
former property has been supported by different studies showing that FDG, like 2-deoxyglucose (2DG), competes 
with glucose for transmembrane carriers (GLUT)3,4 and for hexokinase-catalysed conversion to FDG6P5–7. The 
latter remark has been less clearly illustrated: actually, FDG6P and 2DG6P are false substrates for G6P-isomerase 
and G6P-dehydrogenase (G6PD), channelling G6P to glycolysis and pentose phosphate shunt, respectively5,7,8.
Both substrates can be hydrolysed by G6Pase and thus released into the bloodstream. The assumption at the 
basis of Sokoloff paper1 and of other papers published in the 90s9–11 is that in virtually all cancer lesions FDG6P 
dephosphorylation, though present, is a very slow rate process and can be disregarded at least in the first hour 
after injection.
However, tracer kinetics can be described by a compartmental model12 accounting for three pools which 
implicitly postulates a free access of FDG6P to the catalytic activity of G6Pase (Fig. 1A,C). Specifically, although 
modelling analysis actually indicates that dephosphorylation occurs at a very low rate, Graham et al.13 reported 
that neglecting its contribution systematically causes an underestimation of glucose consumption rate. Further, 
a large literature documented that G6Pase is compartmentalized within the lumen of the endoplasmic reticulum 
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(ER)2,14. On a first hand, this evidence might explain the accumulation kinetics pattern of FDG despite the high 
G6Pase activity observed in cancer15. On the other hand, the presence of a measurable, though limited, hydrolysis 
of FDG6P, in virtually all tissues, intrinsically implies a specific mechanism for its transport across the ER mem-
brane. Indeed, FDG release has been found to reflect the expression of the reticular G6P transporter (G6PT) more 
than that of G6Pase16. These remarks lead to the introduction of a fourth ER compartment as an essential feature 
to model cell FDG retention (Fig. 1B,D).
Our study aimed to verify whether G6Pase sequestration in the ER lumen is compatible with the accumulation 
kinetics of FDG. To this end, a novel in vitro system, able to warrant the needed steady state condition of tracer 
exchanges, was employed to provide the time activity curves (TACs) of FDG uptake in cultured cells. Two models 
were applied to the analysis of tracer kinetics for comparison of the results: the standard Sokoloff model and our 
proposed model accounting for the role of ER (Fig. 1). The results show that ER sequestration of G6Pase is needed 
to explain cell FDG accumulation.
Results
Instrument calibration. FDG kinetics in cells cultured over a Petri dish (PD) was evaluated using a dedi-
cated instrument, LigandTracer White (Uppsala Se) (LT)17–19. As schematized in Fig. 2A,B, LT allows positioning 
of the PD on a plate periodically rotating around an axis inclined at a 30° angle from the vertical. An electron/
positron detector faces the zenith of plate orbit, while the incubation medium is obviously limited to its lowest 
part and thus does not contaminate the counting rate of cultured cells. At each cycle (minute) t, the detector 
measures the counting rates (in counts per second, CPS) of background (BC) and target cells through the whole 
180 minutes experiment duration.
Our first step aimed to estimate the calibration factor needed to convert the measured CPS in activity (Bq) 
and thus to write dimensionally consistent equations. To this purpose, 12 vials containing four mL of incubation 
medium with different glucose concentration (0 mM, n = 4; 5.5 mM, n = 4; 11.1 mM, n = 4) were enriched with 
variable amounts of FDG. Three mL of this radioactive fluid, containing an amount D (Bq) of radioactivity, were 
spilled in the LT-lodged PD and measurements were performed for 60 minutes. At the end of the procedure, the 
medium was accurately collected and its radioactivity content Df (Bq) was measured. The decay-corrected differ-
ence in fluid radioactivity D − Df was thus regarded as the radioactivity contaminating the PD.
As shown in Fig. 2C, the measured counting rate (BC) reached the equilibrium at its maximum value within 
the first minute and remained stable thereafter in all instances. As described in the Methods, this rapid diffusion 
permitted us to estimate the fraction D − Df eventually exposed to positron detector, and the corresponding 
expected counting rate AW
C  (in CPS) generated by emission from the PD wet surfaces and estimated through BC 
(equation (11)). Regression analysis (Fig. 2D) of the whole experimental data set of 12 samples (Table 1) showed 
a tight linear correlation between D − Df and AW
C , regardless either glucose or radioactivity concentrations in the 
spilled fluid. The slope of this line was thus considered the efficiency coefficient e (0.3 CPS/Bq, SEE 2.6 × 10−2 
CPS/Bq).
Figure 1. Biochemical models underlying interpretation of cell FDG uptake. (A) Conventional model 
for FDG kinetics considering G6Pase location within the cytosol. (B) Proposed model for FDG kinetics 
considering G6Pase sequestration within the ER lumen and the transport of FDG6P into the ER by G6PT. 
(C,D) Compartmental representation in terms of the model activities and rate constants.
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This analysis provided us with the method to convert the measured counting rates in time curves of activities 
and thus to estimate the rate constants of exchanges between the different pools, in analogy with the conventional 
analysis of time concentration curves1,4,7–11. In fact, the analysis reported in Supplementary Material S1 indicates 
that this approach provides a unique set of rate constants for each experiment20 and thus ensures that the recon-
structed numerical values of kinetic parameters are the only ones explaining the data21,22. We also observe that the 
estimated rate constants are comparable with the standard ones, with the only exception of FDG rate of entry into 
the cells (k1) that has to be converted into its counterpart (k1) accounting for the ratio between intracellular (Vcyt) 
and medium (Vi) volume, according to the equation:
= .k k
V
V (1)
cyt
i
1 1
Figure 2. Calibration of LigandTracer measurements. (A) Pictorial representation of the front view of the LT 
device: Petri dish radii r = 23 mm, R = 43.5 mm; incubation medium occupying the wet circular segment of 
central angle 2cos−1(r/R); projected detection window as yellow area whose radioactivity is collected by the LT 
detector. (B) Pictorial representation of the lateral view of the LT device, where the height of the wet lateral 
surface is h = 11.85 mm. (C) TACs of the measured background BC (CPS) for three selected cell-free 
experiments: q3 (Gl0) at zero glucose (black line), q7 (Gl1) at glucose concentration 5.5 mM (blue line), and q11 
(Gl2) at glucose concentration 11.1 mM (red line). (D) Simple linear regression on the data couples 
( −D D A,f W
C ) for the twelve cell-free experiments, made at glucose concentration zero (black points), 5.5 mM 
(blue points) and 11.1 mM (red points).
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Uptake experiments. FDG uptake kinetics was evaluated in the murine breast cancer model of 4T1 cells 
seeded in standard PDs according to the procedures described in the Method section. Incubation medium was 
enriched with a known amount of FDG (≅2 MBq/mL) and with two different glucose concentrations: 5.5 mM 
(1 g/L, n = 4, Gl1) and 11.1 mM (2 g/L, n = 4, Gl2).
Experimental conditions are reported in Table 2: the average cell number was 488 ± 213 × 103 (Gl1) and 
513 ± 232 × 103 (Gl2) (p = ns); the administered FDG dose D was 6.87 ± 1.24 (Gl1) and 4.76 ± 0.34 MBq (Gl2) 
(p = ns). In agreement with our previous observation, G6Pase activity of studied 4T1 cells approached values 
previously reported in rat liver homogenates15. Similarly, the rate of catalysis was superimposable for both G6P 
and 2DG6P (1.09 ± 0.13 U/mg vs 1.13 ± 0.16 U/mg, respectively, p = ns), as shown in Fig. 3A.
According to Fig. 3B, the time course of FDG uptake was almost linear in all cell cultures, with small ran-
dom oscillations related to experimental errors of counting statistics. The noticeable difference between the 
curves of the same group is obviously dependent on the product initial dose and number of cells present in each 
experiment.
Compartmental analysis was performed according to both the ER accounting model (4 compartments, 4C) 
and the standard Sokoloff design (3 compartments, 3C)1. As detailed in  Fig. 1, the 4C configuration extends the 
conventional 3C and subdivides intracellular FDG6P pool into two compartments: one accounting for cytosol, 
and one for ER pool, with the latter representing an additional source for the free FDG, besides the extracellular 
input compartment. In other words, 4C assumes that hydrolysis of FDG6P must be preceded by its transport into 
the ER lumen, with a rate constant indexed as k5, while the restitution rate of FDG6P to the free FDG by G6Pase 
is indexed as k6. Free FDG flux from cytosol to ER is disregarded, assuming an early equilibrium warranted by the 
recognized wide abundance of GLUT carriers in the ER membrane23.
Both models provided an excellent fit between reconstructed curves and experimental TACs, with relative 
error being <6% (1.3 ± 0.4% at 5.5 mM, and 5.3 ± 0.2% at 11.1 mM) in all measured times in all experiments 
(Fig. 3C,D). In particular, this analysis proved that the accumulation kinetics of FDG observed in cancer cells is 
compatible with ER sequestration of G6Pase.
Estimated values of the rate constants and their variability among the experiments of the two conditions (Gl1 
vs Gl2) are reported for both 3C and 4C in Table 3. Actually, both models provided similar estimates for trans-
membrane transport both to (k1) and from (k2) cultured cells. By contrast, accounting for the ER compartment 
increased almost six-fold the value of k3 and thus the estimate of FDG phosphorylation rate constant.
Gl (mM) D (MBq) Df (MBq) AW
C  (CPS) %removal
q1 0 6.79 6.78 1.57 × 104 0.11
q2 0 5.17 4.95 6.45 × 104 4.42
q3 0 4.41 4.40 9.63 × 103 0.18
q4 0 4.25 4.08 5.33 × 104 3.96
q5 5.5 5.83 5.74 4.49 × 104 1.62
q6 5.5 4.40 4.35 3.31 × 104 1.21
q7 5.5 3.01 2.99 2.33 × 104 0.48
q8 5.5 1.49 1.44 1.18 × 104 2.90
q9 11.1 6.56 6.37 5.84 × 104 2.94
q10 11.1 4.67 4.55 3.71 × 104 2.54
q11 11.1 3.93 3.84 3.24 × 104 2.25
q12 11.1 2.15 2.11 1.76 × 104 1.75
Table 1. Experimental values for all cell-free experiments, indexed as q1, …, q12: glucose concentration (mM), 
administered FDG activity D (MBq), final FDG activity Df (MBq), end-time value of the wet activity AW
C  (CPS), 
and percentage of FDG removal off the medium (computed as the difference D − Df, over D).
Gl (mM) cell number D (MBq) Acells(180)
e1 5.5 8.00 × 105 8.37 1.73 × 105
e2 5.5 4.50 × 105 6.00 1.46 × 105
e3 5.5 5.00 × 105 5.34 1.11 × 105
e4 5.5 2.00 × 105 7.75 8.88 × 104
e5 11.1 3.50 × 105 5.22 2.29 × 104
e6 11.1 3.00 × 105 4.73 2.13 × 104
e7 11.1 8.00 × 105 4.4 2.03 × 104
e8 11.1 6.00 × 105 4.7 1.10 × 104
Table 2. Experimental values for all the cell experiments, indexed as e1, …, e8: glucose concentration (mM), 
number of cells, administered FDG activity D (MBq), and end-time value of the TAC of FDG inside cells (Acells 
at 180 min).
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Reticular location of G6Pase and intracellular exchanges of phosphorylated hexoses. The met-
abolic response to glucose availability in the incubation medium was differently reconstructed by the two com-
partmental designs. In the 3C model, shifting from Gl1 to Gl2 induced a moderate decrease in k1 and k2, a large 
reduction in k3 and a significant decrease in k4 (Table 3). Switching to the 4C model, obviously provided a rela-
tively more detailed picture. Although responses of free FDG (k1, k2 and k3) reproduced the readout of 3C, 
description of FDG6P fate was markedly different. In fact, doubling glucose concentration virtually halved the 
rate constant of ER radioactivity accumulation (k5) and dephosphorylation-release (k6) (Table 3).
A similar difference between 3C and 4C also applied to the trend of reconstructed compartment activities. 
In the 3C model, shifting from Gl1 to Gl2 experiments almost halved intracellular abundance of free FDG 
(Fig. 4C,D). However, the reduction of k3 caused an even more evident decrease in FDG6P accumulation, as 
documented by the ratio between FDG6P and FDG content Ap/Af that decreased six-fold (from 13.3 ± 1.2 to 
2.5 ± 0.4). 4C estimates of free FDG were remarkably similar with respect to the conventional model. However, 
FDG6P content became dependent upon time, due to a progressive radioactivity transfer to the ER compartment 
(Ar). Actually, cytosolic FDG6P radioactivity Ap was 15% of FDG content in Gl1 experiments and decreased 
down to 4% in Gl2 cultures (Fig. 4E,F). Finally, the most evident response was related to the transfer of intra-
cellular FDG6P toward the ER since the ratio Ar/(Af + Ap) decreased from 14 ± 1.3 in Gl1 to 2.4 ± 0.5 in Gl2 
(p < 0.001, Fig. 4E,F).
Reticular location of G6Pase and Lumped Constant interpretation. FDG accumulation kinet-
ics is usually reconstructed to estimate glucose consumption rate (MRGlu). However, GLUT transport system 
as well as hexokinase and G6Pase catalysis can display different affinities for glucose and FDG. These differ-
ences require normalization through a lumped constant (LC) in order to estimate MRGlu by FDG uptake analy-
sis9,10,13,24. The procedure has been described since the introduction of 2DG method by Sokoloff et al.1. As detailed 
in Supplementary Material S2, conventional estimation of MRGlu can be computed according to the following 
expression:
=
+
MR
LC
k k
k k
C1 ,
(2)Glu glu
1 3
2 3
where Cglu is the concentration of glucose in the medium (in Supplementary Material S2 it has been denoted as 
Ci
g). Shifting measurements from concentrations to activities asks to consider equation (1) and thus to rewrite the 
conventional formulation of equation (2) as follows:
Figure 3. FDG uptake by cultured cells. (A) G6Pase activity of Gl1 and Gl2 cell lysates. No difference could be 
observed for catalytic rate on G6P (blue) and 2DG6P (orange). Similarly, enzyme function was not affected by 
extracellular glucose concentration. (B) TACs of FDG inside cells (Acells) for all the experiments at 5.5 mM (Gl1, 
blue lines) and 11.1 mM (Gl2, red lines). (C,D) Example of model fitting curve as the adherence of the predicted 
curve (black solid line) to selected Gl1 (blue dotted lines) and Gl2 (red dotted lines) experimental data, for the 
3C and 4C designs, respectively. The black fitting line is very difficult to visualize, since the predicted curve 
completely overlaps the experimental dots.
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Figure 4. Glucose consumption and time activity curves of FDG inside model compartments. (A) Comparable 
glucose consumption in Gl1 (blue) and Gl2 (red) experiments measured directly. (B) Glucose consumption 
as estimated by compartmental analysis on FDG uptake, showing a marked decrease in the estimated index 
of glucose intake from Gl1 to Gl2 experiments. (C,D) TACs of the model compartments for the 3C model, for 
both Gl1 and Gl2 experiments. (E,F) TACs of the model compartments for the 4C model, for both Gl1 and Gl2 
experiments. Each panel (C,D,E,F) reports the mean value curves of the TACs computed over the experiments 
of the same group, with e = 0.3 CPS/Bq; the green, orange, and purple curves refer to the free (Af), cytosolic-
phosphorylated (Ap), and ER-phosphorylated (Ar) activities (Bq), respectively. Note that the label of the vertical 
axes of the Gl1 figures (C,E) and of the Gl2 figures (D,F) refers to two different orders of magnitude (104 vs 105).
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To simplify the previous expression (equation (3)), it is convenient to introduce the quantity α defined as
α
+
=
k k
k k
C ,
(4)glu
1 3
2 3
so that the following equation is obtained
α= .¯MR LC V
V (5)
Glu
i
cyt
The coefficient α (equation (4)) can be evaluated by using also the estimated rate constants, or the graphical anal-
ysis proposed by Patlak et al.25 directly applied to the TACs.
In our experimental setting, glucose removal from the incubation medium, i.e. true MRGlu, was similar in Gl2 
and Gl1 experiments (5.2 ± 1.3 nmol × min−1 vs 4.2 ± 1.1 nmol × min−1, respectively, p = ns; Fig. 4A). However, 
using both 3C and 4C compartment models, halving glucose availability (from Gl2 to Gl1) increased α from 
0.21 ± 0.08 nmol × min−1 to 0.74 ± 0.20 nmol × min−1, p < 0.01 (Fig. 4B).
Since the cells were cultured under identical conditions, and the different Gl1 and Gl2 glucose concentrations 
in the medium were used only during the experiment, by applying equation (5) we evaluated the ratio
α
α
=
MR LC
MR LC
V V
V V
/
/
,
(6)
Glu
Glu
i cyt
i cyt
1
2
1
2
where the subscripts 1 and 2 refer systematically to Gl1 and Gl2, respectively; the constants LC and Vi/Vcyt in 
equation (6) can be simplified leading to
α
α
= .
MR
MR (7)
Glu
Glu
1
2
1
2
The left-hand side of equation (7) was evaluated by substitution of the true values of MRGlu, while the right-hand 
side was computed by replacement of the FDG-estimated values for the coefficients α. The resulting estimates 
were
≅ .
MR
MR
0 8,Glu
Glu
1
2
and
α
α
≅ . .3 51
2
3C 4C
k1 k2 k3 k4 k1 k2 k3 k5 k6
Gl1
e1 0.0060 4.9255 0.1080 0.0013 0.0055 4.4798 0.7192 4.4563 0.0015
e2 0.0081 4.5348 0.0994 0.0026 0.0077 4.2792 0.6508 4.6374 0.0030
e3 0.0047 3.7491 0.1226 0.0027 0.0041 3.2282 0.8643 3.5131 0.0033
e4 0.0069 4.3444 0.0503 0.0033 0.0070 4.4844 0.3176 3.4072 0.0035
Mean 0.0064 4.3885 0.0951 0.0025 0.0061 4.1179 0.6380 4.0035 0.0028
SD 0.0014 0.4901 0.0313 0.0008 0.0016 0.6008 0.2314 0.6332 0.0009
Gl2
e5 0.0037 4.0619 0.0267 0.0012 0.0043 4.8096 0.1657 2.5317 0.0012
e6 0.0050 3.7189 0.0169 0.0014 0.0050 3.7482 0.1031 2.0301 0.0014
e7 0.0059 4.2664 0.0152 0.0011 0.0067 4.8754 0.0913 3.1222 0.0011
e8 0.0033 2.5509 0.0051 0.0003 0.0033 2.5782 0.0304 1.7209 0.0003
Mean 0.0045 3.6495 0.0160 0.0010 0.0048 4.0029 0.0976 2.3512 0.0010
SD 0.0012 0.7665 0.0088 0.0005 0.0014 1.0812 0.0554 0.6130 0.0005
Table 3. Rate constants (min−1) of the 3C and 4C models for all the cell experiments, indexed as e1, …, e8, 
made at 5.5 mM (Gl1) and 11.1 mM (Gl2), with e = 0.3 CPS/Bq.
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This largely different response of true MRGlu with respect to its FDG-based estimation, consistent with 
Fig. 4A,B, implies that halving glucose availability causes an immediate increase in LC. As a consequence, LC 
cannot be regarded as constant, but its value depends upon the extracellular glucose concentration, in agreement 
with the data previously reported by Noll et al.11.
In the framework of the 3C model, the only possible explanation for this mismatch is a change in transmem-
brane transport system or hexokinase asset. However, this interpretation seems relatively unlikely, due to the 
sudden nature of observed response. By contrast, it is at least partially explained by the 4C model. As detailed in 
Supplementary Material S2, the metabolic rate of glucose for the 4C model can be written as
=MR k
C
C
C
LC
,
(8)Glu
p
i
glu
5
where Cp = Ap/Vcyt remains constant early after FDG exposure (Fig. 4). We found that doubling glucose con-
centration virtually halves k5 and markedly decreases Ap. Therefore, the combination in equation (8) indicates a 
marked deceleration of FDG6P transport to ER and seems consistent with a selective decrease in ER accumula-
tion of radioactivity, able to explain the marked decrease in LC.
Imaging confirmation. Accounting for the documented sequestration of G6Pase in the ER shifted the com-
partmental description of intracellular FDG kinetics, configuring the same ER as the radioactivity accumulation 
site. To overcome the limited spatial resolution of radionuclide detection and to corroborate this theoretical find-
ing, we thus extended our study by verifying whether this ER fate also applies to the fluorescent 2DG analogue 
2-NBDG. To this purpose, three cell cultures were exposed to a solution containing glibenclamide as a vital ER 
probe, as well as glucose and 2-NBDG at the concentration of 5.5 mM and 50 µM, respectively. Incubation lasted 
20, 50 or 90 minutes before imaging with confocal microscopy with a spatial resolution of 400 nm. Images were 
analysed using a dedicated routine of ImageJ and proved a progressive increase in the colocalization between the 
hexose fluorescence and ER signal (Fig. 5).
Discussion
To the best of our knowledge, this study represents the first characterization of FDG kinetics in cultured cancer 
cells. As expected, the reconstructed time curves of activities following from application of the standard Sokoloff 
model1 fairly fit the data, but the extremely low rate of radioactivity loss disagrees with the high cell G6Pase 
activity. This mismatch may come from a limited access of FDG6P to the hydrolysing enzyme, due to the lumi-
nal localization of G6Pase in the ER2,14. Therefore, existence of the ER pool for FDG6P has been considered; the 
mathematical analysis of data has confirmed this choice by the identification of a continuous tracer transport 
from the cytosol to the ER, a markedly faster rate of hexokinase-catalysed reaction, and accumulation of FDG6P 
in the ER. The last result has also been supported by the independent evidence of a progressive ER accrual of the 
fluorescent FDG analogue 2-NBDG. Thus, the switch from the conventional 3C to the 4C model has provided a 
valuable alternative description of FDG kinetics.
In detail, the standard Sokoloff design implies that FDG retention can be regulated only by transmem-
brane transport and hexose phosphorylation. As a consequence, the combined study of GLUT function and 
Figure 5. Imaging confirmation of radioactivity accumulation in ER. (A) Images obtained with the vital ER 
staining glybenclamide. (B) Simultaneous distribution of the fluorescent 2DG analogue 2NBDG. Images are 
obtained at 20, 50 and 90 minutes, as reported. (C) Colocalization (in white) of ER and 2NBDG signal at a 
spatial resolution of 250 nm. (D) Costes representation of the same images.
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hexokinase activity (or isoforms expression) has been almost invariably adopted to explain variations in 
LC9,10,13,24. Accounting for the acknowledged reticular sequestration of G6Pase deeply modifies the mathematical 
interpretation of tracer uptake mechanisms, and provides a possible explanation for the largely conflicting find-
ings so far provided by the conventional approach. This point is explained by looking at the readout of 3C and 
4C response to doubling competition by glucose molecules in the medium. Applying both models, the shift from 
Gl1 to Gl2 slightly decreases the rate of transmembrane transport as well as the rate of phosphorylation. In the 3C 
model, this effect eventually reduces FDG6P accumulation. In the 4C design, cytosolic FDG6P activity remains 
far lower than free FDG and modestly contributes to overall cell radioactivity content. However, an increase in 
glucose availability causes a profound reduction in ER accumulation, since the marked decrease in the estimated 
content of cytosolic FDG6P is combined with an almost halving of k5. On a practical ground, this observation is 
of limited relevance, since the spatial resolution of positron detection is insensitive to intracellular tracer location. 
However, it has deep theoretical implications since it indicates that G6P competes with FDG6P for G6PT medi-
ated transport from cytosol to ER.
The main features of FDG kinetics resulting from the introduction of the ER pool may be summarized in 
two points: (1) ER significantly contributes to G6P metabolism, and (2) ER contribution to G6P processing 
is inversely related to extracellular glucose availability, thus explaining the previously reported evidence of an 
inverse relationship between LC and glucose availability1,11,26.
Standard compartmental analysis deals with time concentration curves in the different pools to the aim of 
retrieving the rate constants of tracer exchanges. Our procedure modified this approach by writing an equivalent 
system in terms of activities, regarded as the state variables replacing concentrations. The change was motivated 
by several considerations: (1) source data were represented by a cell counting rate that was measured in CPS and 
directly converted in activity (Bq) through the efficiency factor; (2) evaluation of tracer concentration would have 
required an estimation of the total intracellular volume, whose accuracy would have been inevitably hampered 
by the unknown number of cell sources of radioactivity; (3) as detailed in Supplementary Material S1, analys-
ing TACs instead of time concentration curves did not affect values of rate constants describing intracellular 
exchanges, provided that the adimensional ratio v = Ver/Vcyt (i.e. the ratio between ER and cytosol volumes) could 
be considered independent of total number of cells. Relying on previous studies in hepatocytes, the ratio v was 
set at 0.17. Indeed, regardless its numerical value, the ratio was reasonably considered stable over the three hours’ 
duration of the experiment, allowing a reliable estimate of the rates coefficients.
Obviously, despite an apparent reliability of the efficiency coefficient e, conversion of counting rates to activity 
might have been affected by a number of errors, including inaccurate estimates of initial and final medium activ-
ities, non-uniform FDG distribution on the wet surface, non-orthogonal emission from the surface under the 
detector. Accordingly, a test on the effects of variations of e on the reconstructed rate constants was carried out. 
Specifically, each experiment was analysed considering three different e values, namely, the chosen value, corre-
sponding to 1/e = 3, 1/e = 1.8 as minimum, and 1/e = 4.2 as maximum, thus accounting for a variability up to 
40%. Increasing or decreasing e value actually modified significantly k1 (50%) for both the 3C and 4C models. The 
high variability of k1 with respect to alteration of the e value was inherently dependent on modelling assumptions, 
as shown in Supplementary Material S3. On the contrary, the uncertainty of the efficiency coefficient e did not 
affect significantly the estimated values of rate constants associated with intracellular processes: for the 3C model, 
10% of variability for k2 was found, down to <4% for k3 and k4; similarly, for the 4C model, 10% of variability for 
k2, down to <4% for k3 and k6, and 15% for k5. On these grounds, we considered the reconstructed rate constants 
values as sufficiently stable, despite the relative uncertainty in the estimate of e.
The analysis of TACs provided an estimate of the transmembrane tracer exchange rate k1 markedly lower than 
in vivo estimates of k127–31. This apparent mismatch simply reflected the fact that k1 described the tracer exchange 
between cytosolic and incubation volumes, with Vcyt<<Vi. On the other hand, both k1 and k2 were found to be 
independent of the model chosen for the reduction, indicating that the model design did not affect the mathemat-
ical description of transmembrane tracer flux from the medium to the cytosol and vice versa.
FDG6P hydrolysis was estimated to a similar rate by either k4 or k6 for the 3C or 4C model, respectively. In 
agreement with previous literature, reviewed in Table 2 of Reivich et al.32, the numerical values of k4 and k6 were 
very small (in the order of 10−3), suggesting a modest contribution of this process to radioactivity trend. Yet, FDG 
hydrolysis was measurable and its presence led to a deep change in the theoretical description of radioactivity fate 
within a cell. This remark suggests that the a priori constraint k4 = 0 might be a relatively inaccurate procedure, as 
already observed by Graham et al.13.
Regarding k3 estimates, data obtained with 3C model nicely agreed with previous in vivo literature30–32 as 
opposed to the 4C estimates that set this rate constant to markedly higher values. Thus the difference is related to 
the model design: unlike the standard assumption, 4C considers a transfer of phosphorylated hexose to the ER. 
The resulting continuous removal of FDG6P from the cytosol preserves the gradient between FDG6P and FDG 
concentrations. This gradient justifies the estimated high rate of hexokinase-catalysed phosphorylation, which is 
actually close to the rate predicted on the basis of computational modelling of enzyme function estimated by the 
conventional Michaelis-Menten descriptors (Supplementary Material S4).
Besides the already mentioned methodological assumptions, several biochemical considerations have to be 
carefully discussed to correctly interpret the general consequences of our results. As a first point, despite the 
possible general nature of our model, FDG kinetics was only evaluated in cancer cells. Actually, the limited FDG 
uptake in unstimulated normal cells would have hampered TACs analysis.
As a second consideration, the high abundance of GLUT receptors in ER membranes23 justifies the release 
of free FDG from the ER lumen to cytosol, but inevitably implies a transfer in the opposite direction. The con-
sequent direct FDG transfer from cytosol to ER was not considered in 4C and, thus, the present analysis does 
not provide any determination of non-phosphorylated FDG amount within the ER. However, the ER lumen and 
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cytosol can be considered as rapidly exchanging pools reaching relative equilibrium in a rather short time, unless 
a processing machine active on large amounts of non-phosphorylated hexoses is hypothesized in the former 
compartment.
The basis of our mathematical analysis, i.e. the G6Pase localization in the ER lumen, was not directly verified. 
Nevertheless, this interpretation was proposed a long time ago and has been virtually confirmed by all studies 
investigating the regulation of glucose release in the bloodstream14. Moreover, the high G6Pase activity reported 
for both glucose and 2DG is incompatible with a free access of FDG6P to the hydrolytic reaction in the cytosol. 
Similarly, the carrier transferring phosphorylated hexoses across the ER membrane was not clearly identified. 
However, a large literature showed the existence of a dedicated ATP-dependent G6PT. Again, the universally 
recognized evidence of a measurable G6Pase function in virtually all studied tissues intrinsically implies the 
presence of this carrier and its capability to recognize FDG6P as a substrate.
Finally, the present study did not evaluate whether radioactivity release from labelled cells reflected a true 
FDG loss or, rather, the consequence of radiolysis, and thus the loss of 18F− ions. This task was not feasible because 
of the relatively low number of FDG molecules eventually escaping tagged cells. However, this point has been 
reported for the same 4T1 cells, since thin layer chromatography showed that virtually all activity present in the 
medium was accounted by free FDG15.
In conclusion, the present study shows that the acknowledged location of G6Pase function in the ER lumen 
is compatible with FDG kinetics in cultured cancer cells, and deeply modifies our current interpretation of the 
relationship between cell FDG uptake and glucose intake. Accounting for enzyme sequestration implies an almost 
six-fold higher rate of hexokinase catalytic rate. It also implies a continuous transfer of FDG6P from the cytosol 
to ER. The rate of this process is inversely related to the extracellular glucose concentration, and thus indicates a 
relevant access of G6P to G6PT. Despite a high FDG6P concentration combined with a high G6Pase activity in 
the ER lumen, FDG6P hydrolysis is remarkably slow. This disagreement corroborates the concept of a reticular 
metabolic machinery able to process this G6P analogue, and competing with G6Pase to prevent its function15,33. 
The nature of this metabolism, its regulating enzymes, and factors able to modulate its rate cannot be defined in 
the present study. However, should it be confirmed, ER accumulation might configure a new significance for FDG 
uptake, far beyond its current role of accessible index of glucose consumption.
Methods
LigandTracer Calibration. As schematized in Fig. 2A,B, LT encompasses a periodically rotating plate with 
an electron/positron detector facing the orbit zenith, and incubation medium limited to its nadir. For this set of 
experiments, each rotation cycle was divided into 4 intervals: (a) 25 seconds with cell culture in the rotation nadir 
and hence fully immersed in the radioactive medium; (b) 5 seconds for a counter-clockwise rotation of 180°; (c) 
25 seconds with cell culture in the rotation zenith and thus under the detector; (d) 5 seconds for counter-clock-
wise rotation of 180°, leading to cycle restart. At each cycle (minute) t, the detector measures collected counts in 
phases (a) and (c) in order to estimate the counting rates (CPS) of background (BC), and target cells (TC), respec-
tively. The decay corrected difference
= −A T B (9)LT
C C C
is regarded as the time course of the counting rate of radiation emitted by cells through the whole 180 minutes of 
the experiment duration.
Consider now cell-free PDs. The LT may be regarded as a closed system in which the administered radioactive 
dose D is exhaustively distributed in the medium, on the wet surface of the circular ring, and the lateral surface of 
the cylinder of height h (Fig. 2B). Elementary geometric considerations (Fig. 2A,B) lead to evaluation of the total 
emitting wet area SW as:
≈ . × .S 7 5 10 mmW
3 2
The area SW represents the background pool and can be reasonably considered invariant, since the same PDs 
and the same medium volume have been used for all experiments. It was also found that the measured counting 
rate (BC) reached the equilibrium at its maximum value within the first minute and remained stable thereafter for 
all experiments (Fig. 2C). Moreover, a further series of four experiments, in which counting was performed every 
90°, showed that the distribution of sources on the emitting surface could be regarded as homogeneous. Positrons 
received by the detector were regarded as coming from the orthogonal projection of the detection window over 
the PD surface. The detection window of the LT is rectangular in shape with an area of 80 mm2 (8 × 10 mm); 
however, since it points toward the plate with an angle of 20° with respect to the normal, its projection on the PD 
is a surface of area
≈ .S 75 mmpdw
2
The time stability of BC counting rate (in CPS) together with homogeneity led to the proportionality law
=
A
S
B
S
,
(10)
W
W pdw
C C
or, equivalently,
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= ≈A S
S
B B100 ,
(11)
W
W
pdw
C C C
where AW
C  represented the expected counting rate (in CPS) associated with the dose D − Df (in Bq) contaminating 
the wet surface SW of the PD. The conservation law of activity for the closed LT system was thus expressed by the 
linear equation:
= −A e D D( ), (12)W f
C
where for each experiment the counting rate AW
C  were related to BC as in equation (11). Equation (12) defined the 
‘efficiency coefficient’ e (CPS/Bq), for the conversion of Bq to measured CPSs and vice versa, as the slope of the 
regression line determined by the experimental set (Fig. 2D).
Cultured cells. Murine 4T1 breast cancer cells were cultured in standard PDs with 100 mm diameter, inclined 
at 30° from the horizontal plane so as to limit cell presence to the lowest segment of the circular ring. Once 
seeded, cells were maintained in DMEM medium with glucose concentration set at 11.1 mM (2 g/L) enriched 
with 10% fetal bovine serum. For each experiment, a pair of twin cultures was prepared for cell counting and for 
radioactivity measurements, respectively. To this purpose, the PD was placed on the platform of the LigandTracer 
White (Uppsala Se) instrument17–19 schematized in Fig. 2A,B. Cultures were washed with PBS before the admin-
istration of 3 mL of incubation medium. For all experiments, FDG concentration ranged from 1 to 2 MBq/mL. By 
contrast, glucose concentration was set at 5.5 mM (1 g/L, Gl1 n = 4) or 11.1 mM (2 g/L, Gl2 n = 4), respectively. At 
the end of the procedure, G6Pase activity was measured at 660 nm, following the inorganic phosphate production 
according to the Fiske and Subbarow method.
Time activity curve in cultured cells and input function. TACs of cell cultures were reconstructed 
from LT data assuming both a homogeneous metabolic pattern and a uniform distribution of cells over the sur-
face covered by the incubation medium, represented by a circular segment c, described in Fig. 2A, of area 
Sc ≈ 1.1 · 103 mm2. To obtain the estimated TAC of the whole cell culture, denoted as Acells, the LT-measured CPS, 
namely ALT
C  (equation (9)), were normalized according to the following equation:
=A
e
S
S
A1 ,
(13)
cells
c
pdw
LT
C
where the constant
e
S
S
1 c
pdw
was fixed for all experiments at 42 Bq/CPS.
Next, the conservation law of activity was applied to the LT, regarded as closed-system, in order to describe the 
time course of tracer activity in the incubation medium, and thus the input function, in terms of Acells (equation 
(13)). The activity administered at the beginning of an experiment was denoted by D. This activity remained in 
the medium for less than one minute, due to the instantaneous sequestration of the activity =A A e/W W
C  on the 
wet PD surface. Thus, the amount of tracer activity actually available for cell uptake at the beginning of the exper-
iment was set as
= − .A D A (14)i W0
As a consequence of conservation, the tracer contained in the medium at time t (i.e. the input function) was 
determined as the difference:
= − .A t A A t( ) ( ) (15)i i cells0
Mathematical model. The standard approach to compartmental analysis12,34,35 is based on consideration of 
time concentration curves. Within the LT framework, we found convenient to reformulate the mathematical 
problem in terms of TACs, with the caveats and consequences described in Supplementary Material S1. For the 
4C model described in Fig. 1B,D, a system of three linear first-order Ordinary Differential Equations (ODEs) with 
constant rate coefficients k (min−1) was obtained. The system expresses the rate of change of the compartmental 
activities Af, free cytosolic, Ap, phosphorylated cytosolic, and A ,r redefined phosphorylated reticular, as
= − + + +A k k A k A k A( ) (16)f f r i2 3 6 1
= −A k A k A (17)p f p3 5
= −A k A k A (18)r p r5 6
where
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= =k k
V
V
A A
V
V
, ;
(19)
cyt
i
r r
cyt
er
1 1
the superposed dot denotes the time derivative, and explicit reference to time dependence is usually omitted. 
The initial conditions are = = =A A A(0) (0) (0) 0f p r . Here Ai is the given input function (equation (15)). The 
redefined ER activity Ar  is related to the “true” activity Ar through the dimensionless ratio Vcyt/Ver (equation 
(19)), where Vcyt is the total volume of cytosol in the cell culture, and Ver is the corresponding volume of the ER. 
In the definition of k1 (equation (19)), Vi is the volume of the liquid medium, and k1 is the usual rate constant of 
the formulation in terms of concentrations; the same interpretation as rate constants for concentrations holds for 
the coefficients k2, k3, k5, and k6 (see Supplementary Material S1 for details).
The system of ODEs for the activities Af and Ap of the 3C model (Fig. 1A,C) was written as
= − + + +A k k A k A k A( ) (20)f f p i2 3 4 1
= −A k A k A (21)p f p3 4
with initial conditions Af(0) = Ap(0) = 0 and given input function Ai. Here too we set =k k
V
V1 1
cyt
i
. The rate coeffi-
cients k1, k2, k3, and k4 were also pertinent to the description in concentrations.
Comparison with data. In the present framework, the direct problem is the evaluation of the compartment 
activities for any given set of rate constants: for the 4C model, this means solving the system of equations (16), 
(17), (18), given z5 = (k1, k2, k3, k5, k6); for the 3C model, solving equations (20), (21), given z4 = (k1, k2, k3, k4). The 
related inverse problem consists in the determination of z5 or z4 for any given input function Ai(t) (equation (15)) 
and its corresponding total cellular activity Acells(t) (equation (13)). Here, the total activity Acells of cultured cells is 
set equal to the sum of the compartment activities.
In the case of the 4C model, the equation connecting the datum Acells to Af, Ap, and Ar is written as
= + + = + +A A A A A A v A , (22)cells f p r f p r
where v = Ver/Vcyt. Indeed, v is independent of the number of cells and coincides with the ratio of the intracellular 
volumes of ER and cytosol. According to previous studies in hepatocytes36, v was set at 0.17. In the equation con-
necting the datum Acells with the model-compartment activities, the activities depend on the unknown vector of 
parameters z5; consequently, that equation represents the starting point for the formulation and the solution of the 
compartmental inverse problem. Notice that =A v Ar r may be explicitly determined after reconstruction of Ar.
The same procedure holds also for the 3C model, leading to the equation
= +A A A (23)cells f p
for the unknown vector of parameters z4.
It may be shown that the vectors of parameters z5 and z4 can be uniquely determined by the given data (see20). 
The uniqueness property ensures that the numerical values of kinetic parameters obtained by solving the com-
partmental inverse problem are the only values explaining the data21,22. We recall that the compartmental inverse 
problems of equation (22) and equation (23) were solved by means of a Newton-type iterative algorithm37,38, 
already used and validated in other works of our group39–41.
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
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